N4 Pharma Plc's latest marketcap:
As of 08/05/2025, N4 Pharma Plc's market capitalization has reached $4.98 M. According to our data, N4 Pharma Plc is the 44027th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4.98 M |
| Revenue (ttm) | 9,680.69 |
| Net Income (ttm) | -1,407,332.09 |
| Shares Out | 832.28 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/17/2025 |
N4 Pharma Plc's yearly market capitalization.
| Date | Market Cap(£) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/05/2025 | £3.75 M | $4.98 M | 80.7% | 44027 |
| 12/31/2024 | £2.07 M | $2.59 M | -9.28% | 42705 |
| 12/29/2023 | £2.28 M | $2.91 M | -47.18% | 41039 |
| 12/30/2022 | £4.32 M | $5.23 M | -46.33% | 38164 |
| 12/31/2021 | £8.06 M | $10.89 M | -46.71% | 35254 |
| 12/31/2020 | £15.12 M | $20.67 M | 441.9% | 29336 |
| 12/31/2019 | £2.79 M | $3.7 M | -67.19% | 31350 |
| 12/31/2018 | £8.5 M | $10.84 M | 8.89% | 27604 |
| 12/29/2017 | £7.81 M | $10.55 M | 27503 |
Company Profile
About N4 Pharma Plc
N4 Pharma Plc is a specialist pharmaceutical company focused on developing innovative silica nanoparticle delivery systems. These systems are designed to enhance the cellular delivery of cancer treatments, gene therapies, and vaccines, primarily operating in the United Kingdom.
Key Products & Platforms
- Nuvec: A proprietary silica nanoparticle technology featuring an irregular surface structure and polyethyleneimine, which traps and protects nucleic acids for improved therapeutic delivery.
- Liptide: A specialized platform delivering proprietary siRNA sequences to silence fibrotic genes, with potential applications in treating glaucoma.
Company Background
Founded in 1979, N4 Pharma Plc is headquartered in London, United Kingdom, and continues to pioneer advancements in pharmaceutical delivery technologies.
Frequently Asked Questions
-
What is N4 Pharma Plc's (AIM-N4P) current market cap?As of 08/05/2025, N4 Pharma Plc (including the parent company, if applicable) has an estimated market capitalization of $4.98 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does N4 Pharma Plc (AIM-N4P) rank globally by market cap?N4 Pharma Plc global market capitalization ranking is approximately 44027 as of 08/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.